$BABA News CF

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2014 at 2:13 PM

$BABA News

CF Industries rises on merger talks; AstraZeneca, AbbVie fall
13 min ago1:59 p.m. Sept. 23, 2014
- Sue Chang

Let rail cars deliver the returns
12:52 p.m. Today12:52 p.m. Sept. 23, 2014
- The Trading Deck

Why would you own Yahoo shares over Google’s?
12:45 p.m. Today12:45 p.m. Sept. 23, 2014
- Philip van Doorn

Apple and Netflix among gainers as tech stocks rise
10:45 a.m. Today10:45 a.m. Sept. 23, 2014
- Rex Crum

Geopolitical fears sink U.S. stocks
9:56 a.m. Today9:56 a.m. Sept. 23, 2014
- Barbara Kollmeyer

Alibaba’s Jack Ma is China’s richest person
9:31 a.m. Today9:31 a.m. Sept. 23, 2014
- Eva Dou

Hong Kong stocks end lower despite China data surprise
6:08 a.m. Today6:08 a.m. Sept. 23, 2014
- Laura He

This is where the Alibaba IPO went wrong
6:00 a.m. Today6:00 a.m. Sept. 23, 2014
- David Weidner

Did Alibaba’s IPO signal a top in the stock market?
5:50 a.m. Today5:50 a.m. Sept. 23, 2014
- Mark Hulbert

Ascena slides in late trading
5:48 p.m. Sept. 22, 2014
- Tom Bemis

iPhone 6 sales help Apple sidestep broad tech losses
4:48 p.m. Sept. 22, 2014
- Rex Crum

Sigma-Aldrich surges on Merck deal, Alibaba loses steam
4:23 p.m. Sept. 22, 2014
- Sue Chang

Alibaba shares could nearly double IPO price in a year: MKM
12:43 p.m. Sept. 22, 2014
- Tomi Kilgore

Hedge-fund legend Julian Robertson sees bond, stock bubbles
10:12 a.m. Sept. 22, 2014
- William Watts

Small caps may be in trouble, but here’s why Europe is primed
9:45 a.m. Sept. 22, 2014
- Shawn Langlois

Alibaba shares drop 3.4% to $90.74
9:36 a.m. Sept. 22, 2014
- Sue Chang

Alibaba underwriters exercise option to buy additional 48 mln ADS
7:41 a.m. Sept. 22, 2014
- Ciara Linnane

Alibaba says underwriters have exercised option to buy additional 48 mln ADS
7:34 a.m. Sept. 22, 2014
- Ciara Linnane

Newscast: Used car prices crash
5:34 a.m. Sept. 22, 2014
- MarketWatch

Alibaba's big debut sets next hurdles even higher
4:50 a.m. Sept. 22, 2014
- MarketWatch

Yahoo!'s Slide from Alibaba IPO Continues: What Wall Street's Saying

1:08 p.m. Today1:08 p.m. Sept. 23, 2014
- TheStreet.com

Why Isn't Yahoo Worth Significantly More?

11:42 a.m. Today11:42 a.m. Sept. 23, 2014
- Seeking Alpha

BlackRock: Areas of Opportunity for Stocks

11:38 a.m. Today11:38 a.m. Sept. 23, 2014
- Barrons.com

Alibaba falls below $88; Rosenblatt, MKM offer bullish remarks

11:25 a.m. Today11:25 a.m. Sept. 23, 2014
- Seeking Alpha

Stock Market News for September 23, 2014 - Market News

10:10 a.m. Today10:10 a.m. Sept. 23, 2014
- Zacks.com

The Alibaba Debut Bears Uncanny Similarity To A Year 2007 Top Event

9:58 a.m. Today9:58 a.m. Sept. 23, 2014
- Seeking Alpha

Alibaba's IPO Rattles The Global Chessboard

9:18 a.m. Today9:18 a.m. Sept. 23, 2014
- Seeking Alpha

Chinese Roundup: Take Advantage Of The Alibaba IPO And Consider These Stocks On The Dip

9:08 a.m. Today9:08 a.m. Sept. 23, 2014
- Seeking Alpha

Jack Ma Is Richest Person in China

9:03 a.m. Today9:03 a.m. Sept. 23, 2014
- The Wall Street Journal Interactive Edition

Youku Tudou: A Buyout Target?

9:01 a.m. Today9:01 a.m. Sept. 23, 2014
- Seeking Alpha

The Alibaba Opportunity

8:55 a.m. Today8:55 a.m. Sept. 23, 2014
- Seeking Alpha

The Mobile Messaging War: And the Winner is …

8:32 a.m. Today8:32 a.m. Sept. 23, 2014
- FOXBusiness

Analysts Think Alibaba Stock Is a ‘Buy’ … But With Limited Upside

8:15 a.m. Today8:15 a.m. Sept. 23, 2014
- InvestorPlace.com

Move Over Alibaba, These Are The Top 5 IPOs Of 2014

7:02 a.m. Today7:02 a.m. Sept. 23, 2014
- Investors Business Daily

September 23 Premarket Briefing: 10 Things You Should Know

6:54 a.m. Today6:54 a.m. Sept. 23, 2014
- TheStreet.com

Another Big IPO Is Happening This Week (No, It's Not Alibaba)

6:00 a.m. Today6:00 a.m. Sept. 23, 2014
- TheStreet.com

Cramer's Mad Money - The Best IPO Of 2014 (9/22/14)

5:52 a.m. Today5:52 a.m. Sept. 23, 2014
- Seeking Alpha

Don’t Shop for Amazon, Overstock or eBay

5:40 a.m. Today5:40 a.m. Sept. 23, 2014
- InvestorPlace.com

'Fast Money' Recap: It's A Surprisingly Weak Stock Market

5:00 a.m. Today5:00 a.m. Sept. 23, 2014
- TheStreet.com

YHOO: Yahoo Stock Isn’t Worth a Second Look

4:43 a.m. Today4:43 a.m. Sept. 23, 2014
- InvestorPlace.com

Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week
8:15 a.m. Today8:15 a.m. Sept. 23, 2014
- PR Newswire - PRF

Alibaba Brings Internet Sector Back into Focus
8:03 a.m. Today8:03 a.m. Sept. 23, 2014
- ACCESSWIRE

Alibaba Joins FIDO Alliance Board of Directors
8:03 a.m. Today8:03 a.m. Sept. 23, 2014
- Marketwire

Alibaba Group Announces Exercise of Underwriters’ Option to Purchase
Additional ADSs
7:31 a.m. Sept. 22, 2014
- BusinessWire - BZX

Stocks Creating Buzz Today
2:05 p.m. Sept. 19, 2014
- ACCESSWIRE

Alibaba Group Celebrates Initial Public Offering and First Day of
Trading on the New York Stock Exchange
1:37 p.m. Sept. 19, 2014
- BusinessWire - BZX

IPO Value Surges To The Highest Level In More Than a Decade
12:52 p.m. Sept. 19, 2014
- ACCESSWIRE

CORRECTING and REPLACINGAlibaba Group Announces Pricing of
Initial Public Offering
9:14 p.m. Sept. 18, 2014
- BusinessWire - BZX

Alibaba Group Announces Pricing of Initial Public Offering
6:04 p.m. Sept. 18, 2014
- BusinessWire - BZX

KraneShares CSI China Internet ETF (KWEB) delivers a strong one year total return and surpasses $100 million in assets under management ahead of the Alibaba IPO (as of 8/31/2014)
1:21 p.m. Sept. 17, 2014
- PR Newswire - PRF

CBOE and C2 Plan to List Options on Alibaba Group Holding Limited (BABA)
3:09 p.m. Sept. 16, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...